BROADWOOD CAPITAL INC
CIK 1278387 · last filed 2026-04-27
BROADWOOD CAPITAL INC is a corporate insider who has filed 74 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing shows the insider bought $6.1M of OCX on Apr 27, 2026. Across all open-market trades the lifetime net is +$101.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $839.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$839.84M
9
74
$101.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. (OCX) Delisted | 10%+ Owner | 12,685,041 | $3.20 | $40.59M | $75.10M | 7 | 2026-04-27 |
| STAA | 10%+ Owner | 26,526,474 | $28.37 | $752.56M | $62.94M | 37 | 2025-04-07 |
| LCTX | 10%+ Owner | 68,730,970 | $1.27 | $87.29M | $4.03M | 2 | 2022-03-25 |
| BTX | 10%+ Owner | — | $9.03 | — | $0 | 2 | 2017-09-13 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | 10%+ Owner | 27,182,162 | — | — | $46.04M | 10 | 2017-02-17 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | 1,282,050 | — | — | $0 | 1 | 2015-02-11 | |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | Director | 3,636,496 | — | — | -$92.74M | 4 | 2014-08-06 |
| PALOMAR MEDICAL TECHNOLOGIES LLC (PMTI) Delisted | 10%+ Owner | 5,617,246 | — | — | $3.75M | 3 | 2012-06-28 |
| COMARCO INC (CMRO) Delisted | 10%+ Owner | 3,051,668 | — | — | $2.35M | 7 | 2008-04-29 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +1,710,552 | $6.10M | EDGAR |
| 2026-02-12 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +1,565,217 | $9.00M | EDGAR |
| 2025-04-07 | STAA | Buy (P) | +2,535,660 | $40.88M | EDGAR |
| 2025-04-02 | STAA | Buy (P) | +161,907 | $2.82M | EDGAR |
| 2025-03-03 | STAA | Buy (P) | +1,991,283 | $33.83M | EDGAR |
| 2025-02-14 | STAA | Buy (P) | +1,234,290 | $18.82M | EDGAR |
| 2023-11-30 | STAA | Buy (P) | +1,304,973 | $41.11M | EDGAR |
| 2023-11-06 | STAA | Buy (P) | +927,462 | $32.39M | EDGAR |
| 2022-04-15 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Mixed | +18,011,256 | $24.00M | EDGAR |
| 2022-03-25 | LCTX | Buy (P) | +2,790,318 | $3.95M | EDGAR |